← Back to Search

Behavioural Intervention

Experimental for Bleeding disorder

N/A
Waitlist Available
Led By Stan Kachnowski, PhD, MPA
Research Sponsored by Healthcare Innovation Technology Lab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to evaluate the utility and user experience of a smart phone app for people with medical conditions, used in conjunction with an ActiGraph wearable device and a connected scale.

Eligible Conditions
  • Bleeding disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Multiple device intervention 1. SureSource Engage mobile application 2. ActiGraph Link 3. weight scale

Find a Location

Who is running the clinical trial?

BayerIndustry Sponsor
2,274 Previous Clinical Trials
25,514,672 Total Patients Enrolled
Healthcare Innovation Technology LabLead Sponsor
4 Previous Clinical Trials
202 Total Patients Enrolled
Stan Kachnowski, PhD, MPAPrincipal InvestigatorHealthcare Innovation Technology Lab
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top